Researchers examined the prospective associations between perceived parental digital interruptions and mental health symptoms in emerging adolescents.
Sutro strengthens its immuno-oncology pipeline with two new ADCs – Pharmaceutical Technology
Sutro generated $772m in partnership payments as of 30 June 2023. Image Credit: Plufflyman / Shutterstock. Sutro Biopharma plans to submit investigational new drug (IND)